- From PLoS Tech, comes a post Article Level Metrics-Learning to Walk, Run & Do Algebra, featuring links to a recent presentation by bibliometics scholars intended to “provide some guidance and best practices for researchers and research administrators on how to use – and not use – bibliometrics to assess individuals”. The post includes a helpful list of 10 Don’ts.
- The decision by Blue Cross of California to not cover proton beam therapy for prostate cancer has generated some discussion about effectiveness, cost and coverage… Gary Schwitzer of Health News Review writes, Individual insurers doing what feds haven’t in refusing to pay for proton therapy?. Austin Fract has a few posts on this as well on his own blog, and one on JAMA Forum. What do you think?
- Carl Zimmer has an interesting article on gene therapy on Wired.
- A post on Xeconomy, Why Good Drugs Sometimes Fail: the Bexxar Story, quotes Anas Younes of MSKCC.
- The NY Times reviewed George Johnson’s new book, The Cancer Cronicles: Unlocking Medicine’s Deepest Mystery.
- Science magazine covered federal regulator’s efforts to deal with a rise in fecal transplants here.